| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $2,490,155 ) |
| | 2023 | 2023 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DRIVE | BURNABY | BC | | | CAN | R01DA041747 | Localized economic modeling to support implementation of the Ending the HIV Epidemic initiative | 000 | 8 | NIH | 8/30/2023 | $544,551 |
| | 2023 | 2023 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DRIVE | BURNABY | BC | | | CAN | R21DA057058 | The non-fatal overdose crisis: Sex and gender differences in healthcare utilization and health outcomes of people living with and without HIV between 2012 and 2020 | 000 | 1 | NIH | 6/30/2023 | $136,788 |
| | 2023 | 2023 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DRIVE | BURNABY | BC | | | CAN | U01DA038886 | Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS | 005 | 9 | NIH | 5/16/2023 | $1,298,700 |
| | 2023 | 2023 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DRIVE | BURNABY | BC | | | CAN | U01DA038886 | Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS | 006 | 9 | NIH | 6/28/2023 | $0 |
| | 2023 | 2023 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA050629 | DAT-Emulating target trials with big data to strengthen the evidence base for the clinical management of opioid use disorder | 000 | 3 | NIH | 1/27/2023 | $486,752 |
| | 2023 | 2023 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DRIVE | BURNABY | BC | | | CAN | R01AI134299 | Adjuvant, mimicry and booster requirements for shepherding the development of neutralizing antibodies to the high-mannose patch on HIV-1 | 001 | 6 | NIH | 7/26/2023 | $539,999 |
| | 2023 | 2022 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01AI134299 | Adjuvant, mimicry and booster requirements for shepherding the development of neutralizing antibodies to the high-mannose patch on HIV-1 | 000 | 5 | NIH | 2/1/2023 | $0 |
| | 2023 | 2021 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA043408 | An ethno-epidemiological study to advance HIV prevention and treatment for PWUD | 000 | 5 | NIH | 4/4/2023 | $0 |
| | 2023 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DRIVE | BURNABY | BC | | | CAN | F31AT010098 | An Untargeted NMR Metabolomics Platform for Functional Annotation of Natural Product Extracts. | 000 | 3 | NIH | 11/23/2022 | -$4,103 |
| | 2023 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DRIVE | BURNABY | BC | | | CAN | U01DA038886 | Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS | 001 | 6 | NIH | 11/18/2022 | -$526,421 |
| | 2023 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DRIVE | BURNABY | BC | | | CAN | U01DA038886 | Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS | 004 | 6 | NIH | 1/17/2023 | $13,889 |
|
| Issue Date FY: 2022 ( Subtotal = $3,122,123 ) |
| | 2022 | 2022 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA050629 | DAT-Emulating target trials with big data to strengthen the evidence base for the clinical management of opioid use disorder | 001 | 2 | NIH | 3/30/2022 | $49,166 |
| | 2022 | 2022 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R21AI157317 | Relevance of serum mannosidase resistance to the specificity of oligomannose-targeting antibodies | 000 | 2 | NIH | 5/20/2022 | $171,731 |
| | 2022 | 2022 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01AI134299 | Adjuvant, mimicry and booster requirements for shepherding the development of neutralizing antibodies to the high-mannose patch on HIV-1 | 001 | 5 | NIH | 8/23/2022 | $545,999 |
| | 2022 | 2022 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | U01DA038886 | Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS | 000 | 8 | NIH | 4/29/2022 | $1,361,945 |
| | 2022 | 2022 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA050629 | DAT-Emulating target trials with big data to strengthen the evidence base for the clinical management of opioid use disorder | 000 | 2 | NIH | 1/14/2022 | $442,495 |
| | 2022 | 2022 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA041747 | Localized economic modeling to support implementation of the Ending the HIV Epidemic initiative | 003 | 7 | NIH | 8/22/2022 | $550,787 |
| | 2022 | 2021 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA041747 | Localized economic modeling to support implementation of the Ending the HIV Epidemic initiative | 002 | 6 | NIH | 5/9/2022 | $320,992 |
| | 2022 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01AI134299 | Adjuvant, mimicry and booster requirements for shepherding the development of neutralizing antibodies to the high-mannose patch on HIV-1 | 000 | 4 | NIH | 8/23/2022 | $0 |
| | 2022 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA041747 | Localized economic modeling to support implementation of the Ending the HIV Epidemic initiative | 000 | 5 | NIH | 5/9/2022 | -$160,993 |
| | 2022 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA041747 | Localized economic modeling to support implementation of the Ending the HIV Epidemic initiative | 001 | 5 | NIH | 5/9/2022 | -$159,999 |
| | 2022 | 2019 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R21AI127029 | Genetics, dynamics and fitness of the HIV-1 latent reservoir | 000 | 2 | NIH | 12/27/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $3,433,141 ) |
| | 2021 | 2021 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R21AI157317 | Relevance of serum mannosidase resistance to the specificity of oligomannose-targeting antibodies | 001 | 1 | NIH | 6/29/2021 | $116,610 |
| | 2021 | 2021 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R21AI157317 | Relevance of serum mannosidase resistance to the specificity of oligomannose-targeting antibodies | 001 | 1 | NIH | 6/29/2021 | -$116,610 |
| | 2021 | 2021 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R21AI157317 | Relevance of serum mannosidase resistance to the specificity of oligomannose-targeting antibodies | 000 | 1 | NIH | 6/21/2021 | $116,610 |
| | 2021 | 2021 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA043408 | An ethno-epidemiological study to advance HIV prevention and treatment for PWUD | 000 | 5 | NIH | 4/13/2021 | $323,333 |
| | 2021 | 2021 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA043408 | An ethno-epidemiological study to advance HIV prevention and treatment for PWUD | 001 | 5 | NIH | 5/27/2021 | $107,479 |
| | 2021 | 2021 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA050629 | DAT-Emulating target trials with big data to strengthen the evidence base for the clinical management of opioid use disorder | 000 | 1 | NIH | 3/9/2021 | $496,719 |
| | 2021 | 2021 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA041747 | Localized economic modeling to support implementation of the Ending the HIV Epidemic initiative | 002 | 6 | NIH | 8/19/2021 | $563,879 |
| | 2021 | 2021 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | U01DA038886 | Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS | 000 | 7 | NIH | 3/12/2021 | $1,298,700 |
| | 2021 | 2021 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | U01DA038886 | Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS | 001 | 7 | NIH | 3/30/2021 | $0 |
| | 2021 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01AI134299 | Adjuvant, mimicry and booster requirements for shepherding the development of neutralizing antibodies to the high-mannose patch on HIV-1 | 000 | 4 | NIH | 9/17/2021 | $0 |
| | 2021 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA041747 | Localized economic modeling to support implementation of the Ending the HIV Epidemic initiative | 001 | 5 | NIH | 8/10/2021 | $0 |
| | 2021 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | R01DA041747 | Localized economic modeling to support implementation of the Ending the HIV Epidemic initiative | 000 | 5 | NIH | 8/5/2021 | $0 |
| | 2021 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | | | CAN | U01DA038886 | Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS | 002 | 6 | NIH | 6/10/2021 | $526,421 |
|
| Issue Date FY: 2020 ( Subtotal = $2,918,875 ) |
| | 2020 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | V5A 1S6 | | CAN | U01DA038886 | Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS | 005 | 6 | NIH | 4/17/2020 | $1,388,180 |
| | 2020 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | V5A 1S6 | | CAN | R01DA041747 | Localized economic modeling to support implementation of the Ending the HIV Epidemic initiative | 001 | 5 | NIH | 3/6/2020 | $159,999 |
| | 2020 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | V5A 1S6 | | CAN | R01DA041747 | Localized economic modeling to support implementation of the Ending the HIV Epidemic initiative | 000 | 5 | NIH | 1/31/2020 | $498,854 |
| | 2020 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | V5A 1S6 | | CAN | F31AT010098 | An Untargeted NMR Metabolomics Platform for Functional Annotation of Natural Product Extracts. | 001 | 3 | NIH | 9/14/2020 | $4,200 |
| | 2020 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | V5A 1S6 | | CAN | R01AI134299 | Adjuvant, mimicry and booster requirements for shepherding the development of neutralizing antibodies to the high-mannose patch on HIV-1 | 000 | 4 | NIH | 8/12/2020 | $539,341 |
| | 2020 | 2020 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | V5A 1S6 | | CAN | R01DA043408 | An ethno-epidemiological study to advance HIV prevention and treatment for PWUD | 000 | 4 | NIH | 4/1/2020 | $328,301 |
|
| Issue Date FY: 2019 ( Subtotal = $1,473,332 ) (Continued on the next page) |
| | 2019 | 2019 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | V5A 1S6 | | CAN | F31AT010098 | An Untargeted NMR Metabolomics Platform for Functional Annotation of Natural Product Extracts. | 001 | 2 | NIH | 8/16/2019 | $4,200 |
| | 2019 | 2019 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | V5A 1S6 | | CAN | R01DA043408 | An ethno-epidemiological study to advance HIV prevention and treatment for PWUD | 000 | 3 | NIH | 4/22/2019 | $329,543 |
| | 2019 | 2019 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | V5A 1S6 | | CAN | R21AI127029 | Genetics, dynamics and fitness of the HIV-1 latent reservoir | 000 | 2 | NIH | 6/3/2019 | $135,000 |
| | 2019 | 2019 | SIMON FRASER UNIVERSITY | 8888 UNIVERSITY DR SUITE 1200 | BURNABY | BC | V5A 1S6 | | CAN | R01AI134299 | Adjuvant, mimicry and booster requirements for shepherding the development of neutralizing antibodies to the high-mannose patch on HIV-1 | 002 | 3 | NIH | 8/26/2019 | $505,735 |
|
